Yes! India has developed its first indigenously made cervical cancer vaccine, called CERVAVAC. It was created by the Serum Institute of India (SII) in collaboration with the Department of Biotechnology (DBT).
🔹 Why is this a Big Deal?
- Affordable: It's much cheaper than existing HPV vaccines, making it accessible to millions.
- Prevents Cervical Cancer: Targets Human Papillomavirus (HPV) types 16 and 18, which cause around 85% of cervical cancer cases in India.
- Made in India: Reduces dependency on expensive foreign vaccines like Gardasil and Cervarix.
🔹 Why Does it Matter?
Cervical cancer is the second most common cancer among Indian women, with over 75,000 deaths per year. This vaccine could save thousands of lives by preventing infections before they turn into cancer.
The government is planning nationwide vaccination programs to reach young girls before they are exposed to HPV. A huge step for women’s health in India!
Yeah, this is a huge breakthrough! India is set to launch its first indigenously developed HPV (Human Papillomavirus) vaccine to prevent cervical cancer, which is one of the leading cancers among women.
The vaccine, called CERVAVAC, was developed by the Serum Institute of India (SII) in collaboration with the Department of Biotechnology (DBT). It's designed to protect against HPV types that cause most cervical cancer cases.
What makes this even more significant:
- It's expected to be more affordable than international HPV vaccines, making it accessible to millions of women.
- India has a high cervical cancer burden, with over 75,000 cases and 35,000 deaths annually.
- The government is likely to roll it out in a nationwide immunization program for adolescent girls.
This could be a game-changer for women's health in India and globally. Would you like more details on how the vaccine works?
Would you like to know more about how the vaccine works or its rollout plans? 😊
No comments:
Post a Comment